Jain Global’s Cidara Therapeutics CDTX Stock Holding History

Jain Global’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,542	Closed	-$3.43M	–	1260
2025 Q4	$3.43M	Buy	15,542 +9,964	+179%	+$1.61M	0.02%	481
2025 Q3	$534K	Buy	+5,578	New	+$356K	﹤0.01%	731

Jain Global's CDTX Position: Q1 2026 in Review

Jain Global sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 15,542 shares — an estimated $3.43M sold.

Jain Global first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.43M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Jain Global reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Jain Global sold 15,542 Cidara Therapeutics shares in Q1 2026, an estimated $3.43M.
Jain Global first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Jain Global's Cidara Therapeutics position peaked at $3.43M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.